FDA
-
-
-
-
-
-
-
Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025
-
-
-
-
-
-
-
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
-
-
-
-
-
-
-
Dr. Reddys Labs (RDY) Launches Regadenoson Injection 0.4 mg/5 mL in the U.S.
-
-
-
-
-
-
-
Dr. Reddy's Laboratories Announces the Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market
-
-
-
-
-
-
-
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market
-
-
-
-
-
-
-
Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market
-
-
-
-
-
-
-
Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
-
322,864 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

